Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2010
04/21/2010CN1662216B Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid
04/21/2010CN1450890B Novel compositions of minoxidil
04/21/2010CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
04/21/2010CN101695564A Oral liquid for treating verruca vulgaris and preparation method thereof
04/21/2010CN101695544A Composition Chinese medicament for treating leucoderma
04/21/2010CN101695531A Chinese medicinal decoction for treating children alopecia
04/21/2010CN101695514A Traditional Chinese medicinal preparation for treating trauma and cicatricial hyperplasia gargalesthesia and preparation method thereof
04/21/2010CN101695506A Chilblain cream
04/21/2010CN101695505A Preparation method of enzyme hydrolysis pearl powder
04/21/2010CN101695504A Preparation method of nanometer pearl powder
04/21/2010CN101695470A Composite for cosmetics, cosmetic product containing same and preparation method thereof
04/21/2010CN101695469A Mosquito dispelling liquid
04/21/2010CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/21/2010CN101229224B Chinese traditional medicine ointment preparation for curing vitligo and preparing method thereof
04/21/2010CN101167755B Method for preparing centipede polysaccharide protein composition with anti-tumor activity and use
04/21/2010CN101040957B Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same
04/21/2010CN101032599B Healthy solution for conditioning skin and losing weight
04/21/2010CN101028445B Chinese medicine for treating ichthyosis
04/21/2010CN101002866B Traditional Chinese medicine for treating animal injuries
04/20/2010US7700733 Factor VII or VIIa polypeptide variants
04/20/2010US7700660 Method of treating chronic ulcers
04/20/2010US7700657 Vitamin D analogs
04/20/2010US7700655 Antiallergic agents
04/20/2010US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases
04/20/2010US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700271 Method of diagnosis and treatment and agents useful for same
04/20/2010US7700123 Cosmetics
04/20/2010US7700087 Compounds and methods to inhibit or augment an inflammatory response
04/20/2010US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing
04/20/2010US7700081 Psoriasis; applying daily to hair an aqueous mixture of clobetasol propionate, an anionic surfactant, an amphoteric surfactant, and ethanol; leaving it for 2.5 to 15 minutes, and rinsing with water.
04/20/2010US7700080 Oxidation resistance; aging resistance; skin disorders
04/20/2010CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
04/20/2010CA2448829C Preparation for the removal of abnormal keratinous material
04/20/2010CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
04/20/2010CA2433409C Use of mglur5 antagonists for the treatment of pruritic conditions
04/20/2010CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives
04/20/2010CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
04/20/2010CA2368334C Acidic gelled aqueous cosmetic compositions comprising oil-containing biliquid foam dispersion
04/20/2010CA2361587C Methods and compositions to enhance white blood cell count
04/20/2010CA2352572C Humanized antibodies to gamma-interferon
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2229078C Pharmaceutical composition containing il-10
04/20/2010CA2180872C Composition containing nucleic acids, preparation and uses
04/20/2010CA2134756C Selectin variants
04/20/2010CA1341603C Acidic polysaccharide esters and process for their preparation
04/15/2010WO2010042886A2 Pyrone analogs for therapeutic treatment
04/15/2010WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
04/15/2010WO2010041684A1 Tacrolimus preparation for external applications
04/15/2010WO2010040992A1 Quinoline derivatives having dp and / or crth2 receptor activity
04/15/2010WO2010040769A1 PRODUCTION AND USE OF HIGH-PURITY HEMOPARATIDE (hPTH-1-37) FOR THE TREATMENT OF INFLAMMATORY SCALING SKIN DISEASES
04/15/2010WO2010040632A1 Modified release emulsions for application to skin or vaginal mucosa
04/15/2010WO2010040603A1 Dithiolane compounds; compositions containing them; uses for photoprotecting the skin
04/15/2010WO2010040302A1 Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof
04/15/2010WO2010018837A3 Protein cross-linking inhibitor
04/15/2010WO2010018836A3 Polyglutamine aggregation inhibitor
04/15/2010WO2010011611A3 Antimicrobially-primed medicinal maggot therapy
04/15/2010WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs
04/15/2010WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs
04/15/2010US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
04/15/2010US20100094002 Thiazole Compound and Use Thereof
04/15/2010US20100093838 Regulation of angiogenesis with zinc finger proteins
04/15/2010US20100093827 Method for topical treatment of tar-responsive dermatological disorders
04/15/2010US20100093823 Steroidal compounds as melanogenesis modifiers and uses thereof
04/15/2010US20100093818 Benzimidazole derivatives
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
04/15/2010US20100093769 Compounds
04/15/2010US20100093751 Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
04/15/2010US20100093676 Polyaphron topical composition with vitamin d
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093660 Anti-tumor composition comprising tissue-accumulating chitosan gel
04/15/2010US20100093653 Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
04/15/2010US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response
04/15/2010US20100093615 Antibacterial compounds and processes for its production
04/15/2010US20100092582 Topical Hair Care Formulation and Method of Making
04/15/2010US20100092546 Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds
04/15/2010US20100092525 Medical device
04/15/2010US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides
04/15/2010US20100092439 Antimicrobially-primed medicinal maggot therapy
04/15/2010US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects
04/15/2010US20100092432 Cell preparation containing multipotential stem cells originating in fat tissue
04/15/2010US20100092429 Composition
04/15/2010US20100092413 Compositions and Methods for Alleviating Skin Disorders
04/15/2010US20100092400 Salicylic Acid Composition
04/15/2010DE202007019029U1 Grundstoff aus einer Pflanze Raw material from a plant
04/15/2010DE102008050430A1 Anti-Schuppen- und Anti-Rückfall-Shampoo Anti-dandruff and anti-relapse Shampoo
04/15/2010CA2740092A1 Methods for isolating mesenchymal stem cells from embryo of human or animals and extracting secretion substances thereof
04/15/2010CA2740003A1 Pyrone analogs for therapeutic treatment
04/15/2010CA2738831A1 Tacrolimus preparation for external applications
04/15/2010CA2737255A1 Modified release emulsions for application to skin or vaginal mucosa
04/15/2010CA2733262A1 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
04/14/2010EP2174972A1 Alkylene oxide derivative and skin external preparation containing the same
04/14/2010EP2174955A1 Ifnar2 muteins, their production and use
04/14/2010EP2174650A1 Modified release emulsions for application to skin or vaginal mucosa
04/14/2010EP2174647A1 Gel-like composition for external application comprising adenine compound
04/14/2010EP2174640A1 Protective agent against damage of biological tissue caused by near-infrared ray, and product comprising the same
04/14/2010EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity